Literature DB >> 16604192

"Viral déjà vu" elicits organ-specific immune disease independent of reactivity to self.

Doron Merkler1, Edit Horvath, Wolfgang Bruck, Rolf M Zinkernagel, Juan Carlos Del la Torre, Daniel D Pinschewer.   

Abstract

Autoimmune diseases are often precipitated by viral infections. Yet our current understanding fails to explain how viruses trigger organ-specific autoimmunity despite thymic tolerance extending to many non-lymphohematopoietic self antigens. Additionally, a key epidemiological finding needs to be explained: In genetically susceptible individuals, early childhood infections seem to predispose them to multiple sclerosis (MS) or type 1 diabetes years or even decades before clinical onset. In the present work, we show that the innate immune system of neonatal mice was sufficient to eliminate an attenuated lymphocytic choriomeningitis virus (LCMV) from most tissues except for the CNS, where the virus persisted in neurons (predisposing virus). Virus-specific cytotoxic T cells (CTLs) were neither deleted nor sufficiently primed to cause disease, but they were efficiently triggered in adulthood upon WT LCMV infection (precipitating virus). This defined sequence of viral infections caused severe CNS inflammation that was histomorphologically reminiscent of rasmussen encephalitis, a fatal human autoimmune disease. Yet disease in mice was mediated by antiviral CTLs targeting an epitope shared by the precipitating virus and the predisposing virus persisting in neurons (déjà vu). Thus the concept of "viral déjà vu" demonstrates how 2 related but independently encountered viral infections can cause organ-specific immune disease without molecular mimicry of self and without breaking self tolerance.

Entities:  

Mesh:

Year:  2006        PMID: 16604192      PMCID: PMC1430358          DOI: 10.1172/JCI27372

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  Focal seizures due to chronic localized encephalitis.

Authors:  T RASMUSSEN; J OLSZEWSKI; D LLOYDSMITH
Journal:  Neurology       Date:  1958-06       Impact factor: 9.910

2.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

Review 3.  Rasmussen's encephalitis.

Authors:  Yvonne Hart
Journal:  Epileptic Disord       Date:  2004-09       Impact factor: 1.819

4.  Molecular mimicry in diabetes mellitus: the homologous domain in coxsackie B virus protein 2C and islet autoantigen GAD65 is highly conserved in the coxsackie B-like enteroviruses and binds to the diabetes associated HLA-DR3 molecule.

Authors:  G R Vreugdenhil; A Geluk; T H Ottenhoff; W J Melchers; B O Roep; J M Galama
Journal:  Diabetologia       Date:  1998-01       Impact factor: 10.122

5.  Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. A population-based case-control study.

Authors:  G G Dahlquist; S Ivarsson; B Lindberg; M Forsgren
Journal:  Diabetes       Date:  1995-04       Impact factor: 9.461

6.  Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.

Authors:  P S Ohashi; S Oehen; K Buerki; H Pircher; C T Ohashi; B Odermatt; B Malissen; R M Zinkernagel; H Hengartner
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

7.  Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity.

Authors:  R S Fujinami; M B Oldstone
Journal:  Science       Date:  1985-11-29       Impact factor: 47.728

8.  Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland.

Authors:  J Kaprio; J Tuomilehto; M Koskenvuo; K Romanov; A Reunanen; J Eriksson; J Stengård; Y A Kesäniemi
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

9.  Kinetics of protective antibodies are determined by the viral surface antigen.

Authors:  Daniel D Pinschewer; Mar Perez; Eswaraka Jeetendra; Thomas Bächi; Edit Horvath; Hans Hengartner; Michael A Whitt; Juan Carlos de la Torre; Rolf M Zinkernagel
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

10.  THE EPIDEMIOLOGY OF LYMPHOCYTIC CHORIOMENINGITIS IN WHITE MICE.

Authors:  E Traub
Journal:  J Exp Med       Date:  1936-07-31       Impact factor: 14.307

View more
  28 in total

Review 1.  Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host.

Authors:  Didier Hober; Pierre Sauter
Journal:  Nat Rev Endocrinol       Date:  2010-03-30       Impact factor: 43.330

Review 2.  Viruses and Multiple Sclerosis: From Mechanisms and Pathways to Translational Research Opportunities.

Authors:  Alexios-Fotios A Mentis; Efthimios Dardiotis; Nikolaos Grigoriadis; Efthimia Petinaki; Georgios M Hadjigeorgiou
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

3.  Models of autoimmune demyelination in the central nervous system: on the way to translational medicine.

Authors:  Ralf A Linker; De-Hyung Lee
Journal:  Exp Transl Stroke Med       Date:  2009-10-21

4.  T cell-dependence of Lassa fever pathogenesis.

Authors:  Lukas Flatz; Toni Rieger; Doron Merkler; Andreas Bergthaler; Tommy Regen; Mariann Schedensack; Lukas Bestmann; Admar Verschoor; Mario Kreutzfeldt; Wolfgang Brück; Uwe-Karsten Hanisch; Stephan Günther; Daniel D Pinschewer
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

5.  Report on the 1st scientific meeting of the "Verein zur Förderung des Wissenschaftlichen Nachwuchses in der Neurologie" (NEUROWIND e.V.) held in Mittenwalde/Motzen, Germany, Oct. 30th - Nov. 1st, 2009.

Authors:  Tim Magnus; Ralf Linker; Sven G Meuth; Christoph Kleinschnitz; Thomas Korn
Journal:  Exp Transl Stroke Med       Date:  2010-03-31

6.  Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells.

Authors:  Elodie Belnoue; Paola Fontannaz-Bozzotti; Stéphane Grillet; Paul-Henri Lambert; Claire-Anne Siegrist
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

7.  Regulation of immune response and inflammatory reactions against viral infection by VCAM-1.

Authors:  Rong Ou; Menghua Zhang; Lei Huang; Richard A Flavell; Pandelakis A Koni; Demetrius Moskophidis
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

Review 8.  Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis.

Authors:  Patrizia Casaccia-Bonnefil; Giovanna Pandozy; Fabrizio Mastronardi
Journal:  Prog Neurobiol       Date:  2008-09-26       Impact factor: 11.685

Review 9.  Disease-modifying agents for multiple sclerosis: recent advances and future prospects.

Authors:  Til Menge; Martin S Weber; Bernhard Hemmer; Bernd C Kieseier; Hans-Christian von Büdingen; Clemens Warnke; Scott S Zamvil; Aaron Boster; Omar Khan; Hans-Peter Hartung; Olaf Stüve
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  Detection of EBV and HHV6 in the Brain Tissue of Patients with Rasmussen's Encephalitis.

Authors:  Dong Liu; Xin Wang; Yisong Wang; Peigang Wang; Dongying Fan; Sichang Chen; Yuguang Guan; Tianfu Li; Jing An; Guoming Luan
Journal:  Virol Sin       Date:  2018-10-29       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.